Tag: Pradaxa

Invokana class action

Pradaxa Lawsuits Allege Severe and Potentially Fatal Bleeding

More lawsuits have reportedly been added to the Pradaxa litigation against drug maker Boehringer Ingelheim, even after it agreed to pay more than $650 million in settlements in […]

xarelto attorney
Jacob Wackerhausen/iStock/Thinkstock

Study Compares Pradaxa, Xarelto Gastrointestinal Risks to Warfarin’s

Pradaxa and Xarelto gastrointestinal bleeding risks were compared to a more traditional blood thinner, warfarin, in a study published in the April 24, 2015 edition of the British […]

Hip Replacement Infection

Warfarin, Pradaxa Side Effects Compared in 2014 Study

Pradaxa, manufactured and marketed by Boehringer Ingelheim Pharmaceuticals, is a blood thinner that has been linked in studies to an increased risk of internal bleeding. Pradaxa lawsuits have […]

blood thinner xarelto

Blood Thinners Xarelto, Pradaxa Among Drugs Companies Pay Most to Promote

In the last five months of 2013, drug makers spent nearly $20 million to promote medications hospitals and healthcare providers. Among the top 20 drugs listed by Business Insider that companies pay […]

Xarelto Antidote

Xarelto Antidote

When Xarelto and other newer blood thinners were released to the public, they were touted as a better solution to prevent blood clots than Coumadin, also known as warfarin, […]

NSAIDs Injury Risk

Patients Used to Test Those on Bad Drug List

The bad drug list has been in existence for years, often because big pharmaceutical companies push the use of blockbuster drugs to healthcare practitioners. Blockbuster drugs are those […]

Call us today for your free case review(888) 888-0612

Pradaxa Bleeding Is a Common Concern

In what appears to be a rush by the pharmaceutical companies to push new medications to market, problems with many of those medications are becoming more common. The […]

drug recalls

Could Pradaxa Litigation be the Cause of a Drop in Manufacturer Sales?

Boehringer Ingelheim, the German manufacturer of Pradaxa, has seen a five-percent loss in sales over the first half of 2014. During that time the company encountered a number […]

drug recalls

U.S. Set Record Drug Recalls in 2014

The Regulatory Affairs Professionals Society has released a report in which the organization estimates that the number of drug recalls in 2014 may be the highest in history. The U.S. […]

testosterone warning labels

Pradaxa Treatments Approved for Use in the UK

As of July 15th, 2014, Pradaxa treatments are approved in the United Kingdom (UK) to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT and PE are […]

traumatic brain injury

New Pradaxa Study on Patients with Atrial Fibrillation

The German pharmaceutical company Boehringer Ingelheim, which manufactures the oral anticoagulant drug Pradaxa, has launched a new Pradaxa study examining how patients with atrial fibrillation react to using […]

xarelto issues

Lawsuits Filed Over Alleged Xarelto Issues

Last week, a Florida plaintiff brought a Xarelto lawsuit alleging certain Xarelto issues in federal court.  The plaintiff seeks damages sustained by her and her deceased husband who […]

xarelto issues

Antidote Hailed as a Pradaxa Breakthrough

A new antidote, developed by Boehringer Ingelheim, is being hailed as a Pradaxa breakthrough. Pradaxa, a prescription blood thinning agent that reduces the risk of stroke in patients […]

adverse event reports

Adverse Event Reports from Xarelto Patients

Xarelto, an anticoagulant used in the treatment and prevention of deep vein thrombosis, is a prescription-only drug in tablet form. The generic form of the medication is Revaroxaban. […]

xarelto issues

Boehringer Ingelheim Announces $650M Pradaxa Settlement

Boehringer Ingelheim announced on May 28, 2014 an agreement to settle litigation involving their prescription blood thinner Pradaxa (dabigatran). The company estimates that the Pradaxa settlement of $650 […]